New clinical trial is now recruiting in Boston
A new Phase II clinical trial targeting angiosarcoma is now recruiting patients at Boston’s Massachusetts General Hospital and the Dana-Farber Cancer Institute. For details on this and other available trials, check out the recently updated clinical trials page of our website, which is located under our Resources section.
Help keep this research going
Your donation directly funds angiosarcoma-specific research and shared resources that benefit patients worldwide.
